Angiotensin II: A Review of Current Literature

Area of Science:

• Critical Care Medicine
• Pharmacology
• Cardiovascular Research

Background:

• Shock affects up to one-third of intensive care unit patients.
• Angiotensin II is gaining traction across shock types post-FDA approval in 2017.
• Vasoplegic shock was the initial indication for angiotensin II therapy.

Purpose of the Study:

• To review the literature on angiotensin II in shock management.
• To elucidate the mechanism of action of angiotensin II.
• To discuss the benefits and future applications of angiotensin II.

Main Methods:

• Literature review of angiotensin II in shock.
• Analysis of pharmacological mechanisms.
• Synthesis of clinical data and research findings.

Main Results:

• Angiotensin II demonstrates efficacy in various shock states.
• Understanding its mechanism informs therapeutic strategies.
• Emerging data supports expanded use beyond initial indications.

Conclusions:

• Angiotensin II is a valuable therapeutic agent in critical care.
• Further research may uncover novel applications for angiotensin II.
• Its role in managing complex shock is expanding.